ResearcherUniversity Health NetworkNo recent work listed
Raymond M. Reilly
Matched on ORCID iD 0000-0003-1038-7993; OpenAlex author ID A5023465589. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 6
2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper
Papers 7
- Relative Biological Effectiveness (RBE) of [64Cu]Cu and [177Lu]Lu-NOTA-panitumumab F (ab')2 radioimmunotherapeutic agents vs. γ-radiation for decreasing the cl… Last author DOI 10.1016/j.nucmedbio.2023.108367↗
- Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [64Cu]Cu-NOTA-panitumumab F(ab')2 alone or combined with radiosensitizing gemcit… Last author DOI 10.1016/j.nucmedbio.2020.02.001↗
- Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, 111In or β-parti… Last author DOI 10.1186/s41181-020-00111-y↗
- Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelating Polymers Complexed to 177Lu. Last author DOI 10.1021/acs.molpharmaceut.8b01040↗
- Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for Pancreatic Cancer. Last author DOI 10.1021/acs.molpharmaceut.7b01000↗
- EGFR-Targeted Metal Chelating Polymers (MCPs) Harboring Multiple Pendant PEG2K Chains for MicroPET/CT Imaging of Patient-Derived Pancreatic Cancer Xenografts. Co-author DOI 10.1021/acsbiomaterials.6b00649↗
- MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F… Last author DOI 10.1016/j.nucmedbio.2014.10.009↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David William Hedley · 6 shared papers, 2015–2020 · strength 0.64
- Paper Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with A… DOI 10.1186/s41181-020-00111-y↗
- Paper Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [64Cu]Cu-NOTA-panitumumab F(ab')2 alone … DOI 10.1016/j.nucmedbio.2020.02.001↗
- Paper Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelat… DOI 10.1021/acs.molpharmaceut.8b01040↗
- Mitchell A. Winnik · 5 shared papers, 2015–2020 · strength 0.51
- Paper Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with A… DOI 10.1186/s41181-020-00111-y↗
- Paper Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelat… DOI 10.1021/acs.molpharmaceut.8b01040↗
- Paper Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for … DOI 10.1021/acs.molpharmaceut.7b01000↗
- Amanda J. Boyle · 4 shared papers, 2015–2023 · strength 0.50
- Paper Relative Biological Effectiveness (RBE) of [64Cu]Cu and [177Lu]Lu-NOTA-panitumumab F (ab')2 radioimmunotherapeutic agen… DOI 10.1016/j.nucmedbio.2023.108367↗
- Paper Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [64Cu]Cu-NOTA-panitumumab F(ab')2 alone … DOI 10.1016/j.nucmedbio.2020.02.001↗
- Paper EGFR-Targeted Metal Chelating Polymers (MCPs) Harboring Multiple Pendant PEG2K Chains for MicroPET/CT Imaging of Patien… DOI 10.1021/acsbiomaterials.6b00649↗
- Sadaf Aghevlian · 3 shared papers, 2018–2020 · strength 0.37
- Paper Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with A… DOI 10.1186/s41181-020-00111-y↗
- Paper Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelat… DOI 10.1021/acs.molpharmaceut.8b01040↗
- Paper Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for … DOI 10.1021/acs.molpharmaceut.7b01000↗
- Yijie Lu · 3 shared papers, 2017–2019 · strength 0.30
- Paper Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelat… DOI 10.1021/acs.molpharmaceut.8b01040↗
- Paper Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for … DOI 10.1021/acs.molpharmaceut.7b01000↗
- Paper EGFR-Targeted Metal Chelating Polymers (MCPs) Harboring Multiple Pendant PEG2K Chains for MicroPET/CT Imaging of Patien… DOI 10.1021/acsbiomaterials.6b00649↗
- Stéphane Angers · 1 shared paper, 2023 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.